Asia Pacific Dermal Fillers Treatment Market is estimated to witness a rise in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is registering a CAGR of 8.9% during the forecast period 2022-2030
Global Osimertinib Drugs Market is estimated to witness a rise in revenue from US$ 4,828.6 Mn in 2021 to US$ 11,829.8 Mn by 2027. The market is registering a CAGR of 16.1% during the forecast period 2022-2027
The global over-the-counter (OTC) drugs market is expected to experience significant growth, with revenue projected to rise from US$ 1,29,963.03 Mn in 2022 to US$ 2,38,453.92 Mn by 2031, registering a CAGR of 7.0% during the forecast period.
Japan bioanalytical testing services market is projected to make a forward leap in its revenue from US$ Mn 75.6 million in 2023 to US$ 203.0 Mn by 2032. The market is registering a CAGR of 11.6% over the forecast period 2024-2032.
Lateral flow assays (LFAs) are the technology behind low-cost, simple, rapid, and portable detection devices popular in biomedicine, agriculture, food, and environmental sciences. Global Lateral Flow Assay Market, analyzed by Astute Analytica, was valued at US$ 9,535.1 Mn in 2022 and is estimated to reach US$ 14,819.4 Mn by 2031.
The UK Medical Compression Garments Market is estimated to witness a rise in its revenue from US$ 150.3 Mn in 2021 to US$ 238.7 Mn by 2030, registering a CAGR of 5.5% over the forecast period 2022-2030.
Asia Pacific continuous glucose monitoring market is expected to witness a major rise in its revenue from US$ 1,179.9 Mn in 2022 to US$ 3,309.7 Mn by the end of 2031. The market is registering a CAGR of 12.22% over the forecast period.
Japan Epigenetics Market is estimated to witness a rise in revenue from US$ 23.6 Mn in 2021 to US$ 48.6 Mn by 2027. The market is registering at a CAGR of 12.8% during the forecast period 2022-2027
The North America stem cell umbilical cord blood market is estimated to witness a rise in revenue from US$ 1,757.60 Mn in 2022 to US$ 7,051.96 Mn by 2031, at a CAGR of 16.5% during the forecast period 2023–2031.